Scarica l'app Stockscreener
59.60
3.45%
-2.13
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BMY Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Bristol Myers Squibb Co Borsa (BMY) Ultime notizie
Case-By-Case Guide As Justices Eye Landmark Pharma Law - Law360
Trust Co. of Toledo NA OH Sells 55,523 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Elkins, Bristol Myers Squibb CFO, sells $1.85 million in BMY stock - Investing.com Australia
Bristol-Myers Squibb Cancer Moves And Equity Efforts Underpin Valuation Case - Yahoo Finance UK
Growth and Income Portfolio's Bristol-Myers Squibb Co(BMY) Holding History - GuruFocus
Bristol-Myers Squibb Company (BMY) Options Chain - Yahoo! Finance Canada
Elkins, Bristol Myers Squibb CFO, sells $1.85 million in BMY stock By Investing.com - Investing.com South Africa
Bristol Myers Squibb Co. stock underperforms Thursday when compared to competitors - MarketWatch
Bristol-Myers Squibb Co (BMY) Shares Down 3.58% on Apr 2 - GuruFocus
Bristol Myers Squibb Cancer Pact And Equity Push Raise Valuation Questions - simplywall.st
Bristol-Myers Squibb Co Stock (BMY) Moved Down by 3.58% on Apr 2: What Signal Does It Send? - TradingKey
Bristol-Myers Squibb (BMY) Announces Positive Data from the Phase 3 SCOUT-HCM Trial of Camzyos - Insider Monkey
Ritter Alpha, LP's Bristol-Myers Squibb Co(BMY) Holding History - GuruFocus
Tema Etfs LLC Has $6.89 Million Holdings in Bristol Myers Squibb Company $BMY - MarketBeat
20,914 Shares in Bristol Myers Squibb Company $BMY Acquired by J. Safra Sarasin Holding AG - MarketBeat
F&V Capital Management LLC Boosts Holdings in Bristol Myers Squibb Company $BMY - MarketBeat
Allspring Global Investments Holdings LLC Buys 67,783 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
DF Tactical Dividend Fund's Bristol-Myers Squibb Co(BMY) Holding History - GuruFocus
Janux announces development candidate nomination under Bristol Myers collab - tipranks.com
Bristol Myers Squibb Co. stock outperforms competitors on strong trading day - MarketWatch
Bristol Myers Squibb Target of Unusually High Options Trading (NYSE:BMY) - MarketBeat
Piramal Pharma Completes Acquisition of Kenalog Injectable Product from Bristol-Myers Squibb - scanx.trade
Bristol Myers Squibb (BMY) Partners with Janux on New Cancer The - GuruFocus
Janux Unveils Development Candidate in Bristol Myers Squibb Partnership, Worth $35M Milestone - Contract Pharma
Janux Therapeutics receives $35M milestone from Bristol Myers Squibb - Investing.com
Janux Therapeutics receives $35M milestone from Bristol Myers Squibb By Investing.com - Investing.com India
Janux Therapeutics Announces Development Candidate Nomination Under Bristol Myers Squibb Collaboration, Triggering $35 Million Milestone Payment - Yahoo Finance Singapore
Bristol Myers Squibb Company $BMY Shares Sold by Meyer Handelman Co. - MarketBeat
Advanced Renal Cell Carcinoma Treatment Market to Grow by $3.1 Billion During 2026-2030: Global Industry Assessment Featuring Pfizer, Merck & Co., Bristol-Myers Squibb, AstraZeneca, Novartis and More - finance.yahoo.com
Bristol Myers Squibb Co. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Bristol Myers Squibb Discounts Sotyktu, Zeposia, Orencia SC on Government SiteNews and Statistics - indexbox.io
Bristol Myers Squibb Co. stock rises Tuesday, still underperforms market - MarketWatch
Bristol Myers Squibb Stock: Dividend Reliability and Pipeline Momentum Define Investor Appeal in 202 - AD HOC NEWS
Is Bristol Myers Squibb (BMY) Price Near US$60 Supported By Cash Flow And Earnings Models - simplywall.st
Kidney Cancer Drugs Market to Grow by $2 Billion During - globenewswire.com
Kidney Cancer Drugs Market to Grow by $2 Billion During 2026-2030: Pfizer, Novartis, Exelixis, Roche, Bristol Myers Squibb Company, and Bayer Lead the Industry - Yahoo Finance
Ovarian Cancer Drugs Market Outlook Report 2026-2030 - GlobeNewswire
Ovarian Cancer Drugs Market Outlook Report 2026-2030 Featuring Strategic Analysis of AstraZeneca, Roche, Bristol-Myers Squibb Company, Clovis Oncology, Pfizer and Other Key Players - Yahoo Finance
Bristol Myers Squibb launches survey on myeloma care gaps By Investing.com - Investing.com India
Mn Services Vermogensbeheer B.V. Increases Stock Position in Bristol Myers Squibb Company $BMY - MarketBeat
Retirement Systems of Alabama Boosts Position in Bristol Myers Squibb Company $BMY - MarketBeat
Bristol Myers Squibb adding 3 medications on TrumpRx - Fox Business
Multiple Myeloma Market Is Going to Boom Rapidly | Bristol-Myers - openPR.com
Should You Buy Bristol-Myers Squibb Company (NYSE:BMY) For Its Upcoming Dividend? - simplywall.st
Bile Duct Cancer Market to Grow by $1.07 Billion During 2026-2030: Key Trends, Investment Opportunities and Competitive Strategies Analyzed - GlobeNewswire Inc.
Pancreatic Adenocarcinoma Treatment Market to Grow at 13% CAGR During 2026-2030, Led by Pfizer, Roche, Merck & Co., Sanofi, Bristol-Myers Squibb, AstraZeneca, Novartis, and GlaxoSmithKline - Yahoo Finance
Bristol-Myers Squibb Gets FDA Approval for Hodgkin’s Lymphoma Treatment - Insider Monkey
Jim Cramer on Bristol-Myers Squibb: “The stock’s recent pullbacks have represented terrific buying opportunities” - MSN
Is Bristol-Myers Squibb Company (BMY) A Good Stock To Buy Now? - Insider Monkey
Bristol Myers Squibb Stock: Strong Growth Portfolio and Dividend Yield Position BMY Shares as a Valu - AD HOC NEWS
Bristol Myers Squibb’s Camzyos shows promise in adolescent trial By Investing.com - Investing.com UK
Bristol Myers Squibb’s Camzyos shows promise in adolescent trial - Investing.com
Heart drug cuts blockage in teens with rare heart disease, trial shows - Stock Titan
A Look At Bristol Myers Squibb (BMY) Valuation As Growth Portfolio Outperforms Recent GAAP Loss - simplywall.st
Bristol-Myers Squibb (BMY) Faces Mixed Analyst Sentiment Despite Strong Momentum in Healthcare Industry - Insider Monkey
Wedge Capital Management L L P NC Decreases Stake in Bristol Myers Squibb Company $BMY - MarketBeat
Neuroscience data release drives Bristol-Myers Squibb stock lower 1.50% - tradersunion.com
BMY Stock Quote Price and Forecast - CNN
Bristol-Myers Squibb Co (MIL:1BMY) Bonds - GuruFocus
Bristol Myers Squibb Co. stock underperforms Friday when compared to competitors - MarketWatch
Jim Cramer on Bristol-Myers Squibb: “The Stock’s Recent Pullbacks Have Represented Terrific Buying Opportunities” - Insider Monkey
Anti-Cancer MAbS Market Report 2026-2030 Featuring - globenewswire.com
Anti-Cancer MAbS Market Report 2026-2030 Featuring Strategic Analysis of Amgen, Bristol Myers Squibb Company, Eli Lilly and Company, Roche, GlaxoSmithKline and Other Key Players - Yahoo Finance UK
Integras Partners LLC's Bristol-Myers Squibb Co(BMY) Holding History - GuruFocus
Global X Japan Co. Ltd. Raises Stock Position in Bristol Myers Squibb Company $BMY - MarketBeat
0.81%
1.37%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):